fluorodeoxyglucose f18 has been researched along with Neurofibromatosis 2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anton-Rodriguez, JM; Coope, D; Djoukhadar, I; Evans, DG; Jackson, A; Julyan, P; King, AT; Lewis, D; Lloyd, SKL; Matthews, JC; Russell, D | 1 |
Hanemann, CO; Kaempchen, KE; Kaufmann, D; Krause, BJ | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Neurofibromatosis 2
Article | Year |
---|---|
[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.
Topics: Adult; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2019 |
Fludeoxyglucose F 18 positron emission tomography and computed tomography of a giant retroperitoneal schwannoma occurring in a patient with neurofibromatosis type 2.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Kidney; Lumbosacral Plexus; Male; Neurilemmoma; Neurofibromatosis 2; Positron-Emission Tomography; Retroperitoneal Neoplasms; Retroperitoneal Space; Spinal Nerve Roots; Tomography, X-Ray Computed; Treatment Outcome | 2005 |